Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7499539 | 0.76 | TRPA1 (0.35) | ALDH1A1MAPTFFAR1CYP19A1RXRA | |
| SCHEMBL835461 | 0.76 | ALDH1A1 (0.30) | ALDH1A1MAPTFFAR1CYP19A1RXRA | |
| SCHEMBL7499542 | 0.76 | TRPA1 (0.35) | ALDH1A1MAPTFFAR1CYP19A1RXRA | |
| SCHEMBL6702321 | 0.76 | — | — | |
| SCHEMBL27483485 | 0.74 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL107762 | 0.74 | — | — | |
| SCHEMBL107763 | 0.74 | — | — | |
| SCHEMBL30139864 | 0.72 | ALDH1A1 (0.33) | ALDH1A1MAPTFFAR1CYP19A1RXRA | |
| SCHEMBL21411540 | 0.71 | — | — | |
| SCHEMBL387577 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11931445-B2 | Composition comprising baicalin | L'OREAL (FR) | 2024-03-19 | — | — | US | disclosed |
| WO-2023067251-A1 | COMPOSITION FOR USE IN THE CUTANEOUS SYNTHESIS OF HYALURONIC ACID, IN AN IMMUNO-CUTANEOUS RESPONSE AND TO IMPROVE SKIN | JR (FR) | 2023-04-27 | — | — | WO | disclosed |
| EP-3558253-B1 | COMPOSITION COMPRISING BAICALIN | OREAL (FR) | 2022-12-28 | — | — | EP | disclosed |
| US-20200093724-A1 | COMPOSITION COMPRISING BAICALIN | L'OREAL (FR) | 2020-03-26 | — | — | US | disclosed |
| EP-3558253-A1 | COMPOSITION COMPRISING BAICALIN | L'Oreal (FR) | 2019-10-30 | — | — | EP | disclosed |
| WO-2018115360-A1 | COMPOSITION COMPRISING BAICALIN, A FATTY ACID ESTER AND AN ALKYLPOLYGLYCOSIDE | L'OREAL (FR) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018115493-A1 | COMPOSITION COMPRISING BAICALIN | L'OREAL (FR) | 2018-06-28 | — | — | WO | disclosed |
| US-20110288100-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | PURDUE PHARMA L.P. (US) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11931445-B2 | Composition comprising baicalin | KRT18, S100A6, DSG1 | ALDH1A1 2732/4885MAPT 1721/4885FFAR1 3093/4885 |
| US-20110288100-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | OPRL1, OPRK1, MTNR1A | ALDH1A1 652/4885MAPT 2712/4885FFAR1 1385/4885 |
| US-20200093724-A1 | COMPOSITION COMPRISING BAICALIN | KRT18, S100A6, DSG1 | ALDH1A1 2732/4885MAPT 1721/4885FFAR1 3093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.